Nourianz User Reviews & Ratings
Nourianz has an average rating of 6.0 out of 10 from a total of 3 reviews on Drugs.com. 67% of reviewers reported a positive experience, while 33% reported a negative experience.
| Condition | Avg. Rating | Reviews | Compare |
|---|---|---|---|
| Parkinson's Disease | 3 reviews for Parkinson's Disease | 55 medications |
- Par...
- Taken for 6 months to 1 year
- January 28, 2021
For Parkinson's Disease "Been taking Nourianz 20 mg for 8 months along with Rytary. Together, they have helped my rigidity. Have not experienced any side effects from either medication."
- Kel...
- Taken for 1 to 2 years
- February 26, 2024
For Parkinson's Disease "Good drug; had to stop taking it because of cost. Bummer, patent does not expire until 2027 - no competition."
Are you taking this medicine?
Your review helps others make informed decisions.Reviews may be edited to correct grammar/spelling or remove inappropriate content. Reviews appearing to come from parties with a vested interest are not published. This information is not intended to endorse any medication and should not replace the expertise and judgment of healthcare professionals.
More about Nourianz (istradefylline)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (3)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antiparkinson agents
- En español
For Parkinson's Disease "A useful medication - if you can afford it. Being on Medicare means you are on a 'government' plan, and you will get no assistance from any program. So once again, retirees are screwed by the drug companies that 'offer' assistance programs."